Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
GLOBETECH PUBLISHING LLC
Schiller

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

By Medimaging International staff writers
Posted on 18 Aug 2014
Riverain\'s ClearRead bone suppression software
An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Medical)
Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or are in the process of buying. New bone suppression technology helps radiologists identify lung nodules and other serious medical conditions by converting a traditional chest X-ray into a soft tissue image without the ribs and clavicle bones.

These structures typically obscure abnormalities. There are no further testing or radiation exposure for patients, and no need for imaging units or hardware for the hospital to buy or house to achieve the soft tissue image.

Riverain Technologies (Dayton, OH, USA) revenues increased 34% year-over-year through the first half of 2014 based on strong adoption of the company’s ClearRead software solutions. This was particularly true among academic medical centers and community and Veterans Administration (VA) hospitals throughout the US Midwest. “Most of the growth in adoption is being driven by radiologists’ recognition that bone suppression is very useful and there’s little to no downside to it,” said Heber MacMahon, MB, BCh, professor of radiology and director of thoracic imaging at the University of Chicago Medical Center (IL, USA).

In the past, no-bone, soft tissue images were only made possible by exposing patients to higher radiation levels using costly imaging equipment. The enhancements in clarity and performance of the X-ray are advantageous for patients because that X-ray is the most readily available and widely used imaging modality. Many lung tumors are first targeted on X-ray images taken for other reasons, such as to diagnose other medical conditions, including heart problems, broken ribs, collapsed lung, pneumonia, and emphysema.

“It’s nice to get more out of what we deliver,” said Ella Kazerooni, MD, past president of the Society of Thoracic Radiology, and professor and director, division cardiothoracic radiology, and associate chair for clinical affairs at the University of Michigan (U-M) Health System (Ann Arbor, USA). “The software is easy to install, easy to train to, and, frankly it provides immediate clinical value.”

The software is sold directly to medical centers, to enhance X-ray images captured by the machines they already have, and by major manufacturers including Siemens Healthcare (Erlangen, Germany) and Philips Healthcare (Best, The Netherlands) as a value-added extension to new X-ray equipment.

University of Chicago (IL, USA) bought ClearRead software after serving as a research site and validating the effectiveness of Riverain’s ClearRead bone suppression and computer-aided diagnosis (CAD) software, ClearRead +Detect, in improving the diagnostic potential of traditional X-ray images. “As long as we’re going to continue to do millions of chest X-rays around the world, with this software we’re going to pick up more cancers sooner and we’re going to miss less cancers,” said Dr. MacMahon, who is a member of Riverain’s medical advisory board.

In addition to purchasing ClearRead bone suppression and ClearRead + Detect software, which marks suspected lung nodules on an X-ray image, U-M Health System physicians are planning on purchasing of ClearRead +Confirm software, based on a clinical evaluation of the software.

ClearRead +Confirm identifies and highlights lines and tubes on portable chest X-ray images, reducing reading time by approximately 19% without compromising radiologist accuracy or confidence. “Referring physicians working in our intensive care units can see lines and tubes much more clearly without having to make adjustments to each image, line by line and case by case,” Dr. Kazerooni said. “They’re bypassing the standard X-ray image and going directly to the Riverain-processed images. This speaks to how highly they regard the software.”

The benefit of ClearRead +Confirm for patients, Dr. Kazerooni added, is that “It gives us greater confidence about the devices we’re putting in place so that we’re sure they’re functioning optimally.”

Riverain Technologies’ ClearRead software enhances the expert skills of radiologists to improve patient outcomes using standard chest X-ray, without additional radiation dose or procedures for patients. Riverain ClearRead software solutions include ClearRead bone suppression, +Detect, +Confirm and +Compare, which reveals density alterations between current and earlier chest X-ray images.

Related Links:

Riverain Technologies




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
Free digital version edition of Medical Imaging International sent by email on regular basis
Free print version of Medical Imaging International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Medical Imaging International in digital format
Free Medical Imaging International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


Channels

Radiography

view channel
Image: Fujifilm\'s Aspire Cristalle (Photo courtesy of Business Wire).

Diagnostic Imaging Solutions Provider Submits Mammography Upgrade for FDA Approval

A leading provider of medical informatics solutions and diagnostic imaging products has submitted the first of several modules of its Digital Breast Tomosynthesis (DBT) upgrade for its mammography system,... Read more

MRI

view channel

Alzheimer’s Disease Linked to Specific Lifestyle Risk Factors

The results of a new study have found that cardiovascular risk factors such as smoking, alcohol consumption, diabetes, and obesity, can be linked directly to smaller brain volumes in specific areas of the brain, and to lower cognitive test scores. The study was published online in the Radiological Society of North America... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Industry News

view channel

Guerbet Aims for Global Medical Imaging Leadership by Acquisition of Mallinckrodt’s CMDS Business

Guerbet (Paris, France) has announced a definitive agreement for the acquisition of the Contrast Media and Delivery Systems (CMDS) business of pharmaceutical giant Mallinckrodt (Chesterfield, Derbyshire, UK). The acquisition gave Guerbet and the CMDS unit combined pro-forma sales of nearly EUR 800 million in 2014, a... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.